申请人:Acuitas Therapeutics, Inc.
公开号:US20190022247A1
公开(公告)日:2019-01-24
Compounds are provided having the following structure (I) or (II): or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R, R
1
, R
2
, L, X, L, G
1
, G
2
, Z, a
1
, a
2
and n are independently as defined herein for each of structures (I) and (II). Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.